Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05222321 · ClinicalTrials.gov registry record · NA

Sensory-Play Based (SenPlay) Intervention for Young Children With or At Risk for ADHD

A NA study, sponsored by University of Oklahoma.

Terminated
Registry status
NA
Development phase
12
Enrollment target

NCT05222321: Clinical Trial NA study, sponsored by University of Oklahoma.

NCT05222321 is a NA study that was terminated before completion, run by University of Oklahoma. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05222321, a NA study, was terminated before completion, sponsored by University of Oklahoma.

TERMINATED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

The purpose of this pilot study is to determine the effects of 15 minutes of sensory-play based (SenPlay) intervention on improving focused attention in developmentally appropriate tasks in young children with or at risk for ADHD.

Primary Outcome

Momentary Time Sampling (MTS) using a MTS observation chart will be used to code on and off task behaviors when engaged in developmentally appropriate task (DAT) for three sessions per participant. Sessions will be recorded using a video camera and coded to ensure completeness of data tracking for on and off-task behaviors. Using MTS, the child's behavior is coded at the beginning of every 15 second time interval using a stopwatch to ensure 15 second intervals. Focused attention will be measured

Interventions

  • OTHER Sensory-Play Based (SenPlay) Intervention
  • OTHER Spontaneous, Free Play

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2022-03-09
Est. Completion 2022-05-19
Phase NA
University of Oklahoma

358 total trials

Why NCT05222321 stopped before completion

NCT05222321 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Sensory-Play Based (SenPlay) Intervention is the first listed.

NCT05222321 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05222321 about?

NCT05222321 is a clinical study titled "Sensory-Play Based (SenPlay) Intervention for Young Children With or At Risk for ADHD". The purpose of this pilot study is to determine the effects of 15 minutes of sensory-play based (SenPlay) intervention on improving focused attention in developmentally appropriate tasks in young children with or at risk for ADHD.

What is the current status of trial NCT05222321?

This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2022-03-09. Estimated completion is 2022-05-19.

What interventions are being tested in trial NCT05222321?

The interventions under investigation include: Sensory-Play Based (SenPlay) Intervention (OTHER), Spontaneous, Free Play (OTHER).

Who is sponsoring clinical trial NCT05222321?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05222321's enrollment target sits among peer trials

12 1913th of 2000 higher than 74 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05222321, the US trial registry maintained by the National Library of Medicine. NCT05222321 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.